Monogenic and Polygenic Models of Coronary Artery Disease

[1] Topol EJ(2019)High-performance medicine: the convergence of human and artificial intelligence Nat Med 25 44-56

[2] Khera AV(2017)Genetics of coronary artery disease: discovery, biology and clinical translation Nat Rev Genet 18 331-344

[3] Kathiresan S(2018)A decade of genome-wide association studies for coronary artery disease: the challenges ahead Cardiovasc Res 114 1241-1257

[4] Erdmann J(2019)Genetics of common, complex coronary artery disease Cell. 177 132-145

[5] Kessler T(2008)Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2 BMJ. 336 1475-1482

[6] Munoz Venegas L(2019)2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines J Am Coll Cardiol 74 e177-e232

[7] Schunkert H(1982)Familial aggregation of coronary heart disease and its relation to known genetic risk factors Am J Cardiol 50 945-953

[8] Musunuru K(2018)The personal and clinical utility of polygenic risk scores Nat Rev Genet 19 581-590

[9] Kathiresan S(1994)Genetic susceptibility to death from coronary heart disease in a study of twins N Engl J Med 330 1041-1046

[10] Hippisley-Cox J(2004)Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring JAMA. 291 2204-2211

[1] Topol EJ(2019)High-performance medicine: the convergence of human and artificial intelligence Nat Med 25 44-56

[2] Khera AV(2017)Genetics of coronary artery disease: discovery, biology and clinical translation Nat Rev Genet 18 331-344

[3] Kathiresan S(2018)A decade of genome-wide association studies for coronary artery disease: the challenges ahead Cardiovasc Res 114 1241-1257

[4] Erdmann J(2019)Genetics of common, complex coronary artery disease Cell. 177 132-145

[5] Kessler T(2008)Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2 BMJ. 336 1475-1482

[6] Munoz Venegas L(2019)2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines J Am Coll Cardiol 74 e177-e232

[7] Schunkert H(1982)Familial aggregation of coronary heart disease and its relation to known genetic risk factors Am J Cardiol 50 945-953

[8] Musunuru K(2018)The personal and clinical utility of polygenic risk scores Nat Rev Genet 19 581-590

[9] Kathiresan S(1994)Genetic susceptibility to death from coronary heart disease in a study of twins N Engl J Med 330 1041-1046

[10] Hippisley-Cox J(2004)Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring JAMA. 291 2204-2211